On D8 and D15 of induction therapy, the B-ALL patients showed a similar production profile, with high frequency/levels of CD4+ T, CD8+ T, Treg, IFN-γ, CCL2 and, selectively, IL-10 and NKT, on D8 and D15, respectively. Here, CCL2 is linked to acute lymphoblastic leukemia.